Hypofractionated radiotherapy for prostate cancer: a bibliometric analysis

Read full text Summarise with VIRAT
Authors: Lingling Meng, Yupeng Di, Yingjie Wang, Baolin Qu
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This comprehensive bibliometric analysis of 1,428 publications from the WoSCC reveals the rapid expansion and maturation of research on hypofractionated radiotherapy (HFRT) for prostate cancer, characterized by an average annual growth rate of 13.28% since 2020. Led by prominent contributions from the United States, Italy, and the University of Toronto, the field has evolved from foundational radiobiological concepts and early conformal techniques toward current research hotspots focused on high-precision delivery, such as image-guided radiotherapy (IGRT) and stereotactic body radiation therapy (SBRT), as well as robust clinical validation through randomized non-inferiority trials. The findings highlight a multidisciplinary ecosystem that increasingly integrates technological advancements with quality-of-life assessments. Moving forward, the research trajectory is expected to prioritize personalized adaptive radiotherapy, biomarker integration, and the resolution of practical implementation challenges to further refine and enhance clinical outcomes for prostate cancer patients.

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Advanced Radiotherapy Techniques Advances in Oncology and Radiotherapy

Publication details

Journal / source
Discover Oncology
Volume
17
Issue
1
Publication date
25 March 2026
Language
EN